Guardant Health (GH) Asset Writedowns and Impairment (2022 - 2025)

Guardant Health (GH) posted Asset Writedowns and Impairment of $13.6 million for Q4 2025, up 171.64% sequentially from $5.0 million in Q1 2025.

Guardant Health (GH) Asset Writedowns and Impairment (2022 - 2025) Analysis & Trends

Guardant Health (GH) has 3 years of Asset Writedowns and Impairment data on file, last reported at $13.6 million in Q4 2025.

  • Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $13.6 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $13.6 million (up 171.64% YoY) and the FY2025 annual result came in at $18.6 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment advanced to $13.6 million in Q4 2025 per GH's latest filing, from $5.0 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $23.6 million in Q2 2023, with the low at $5.0 million in Q1 2025.
  • Average Asset Writedowns and Impairment over 3 years is $10.6 million, with a median of $5.5 million recorded in 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn
10 Guardant Health 22.42 Bn 21.31 Bn 196.75 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 13.58 Mn
Dec 31, 2025 13.58 Mn
Mar 31, 2025 5.00 Mn
Mar 31, 2025 5.00 Mn
Jun 30, 2023 23.57 Mn
Jun 30, 2023 23.57 Mn
Mar 31, 2023 5.49 Mn
Mar 31, 2023 5.49 Mn
Sep 30, 2022 5.26 Mn
Sep 30, 2022 5.26 Mn